About 20% of all GBS patients have symptoms of dysautonomia:labile hyperten
sion, orthostatic hypotension, sinustachycardia or sinus arrest. This rate
rises to 75% in patients with tetraplegia. Proprioceptive loss predicts dys
autonomia independently from the severity of weakness. It is frequently res
ponsible for dysautonomia. The afferent limb of cardiovascular regulation c
ontains more myelinated fibers than the sympathetic and parasympathetic eff
erences, which determine the common classification of dysautonomia. The fre
quence of mixed sympathetic and parasympathetic hyperactivity is hard to ex
plain by efferent lesions. Afferent conduction block releases the sympathet
ic efference of the baroreceptor reflex. The resulting catecholamine excess
explains hypertension, tachycardia, EGG-changes and hyperglycemia. Norepin
ephrine sensitizes left ventricular stretch receptors. They induce cardiova
scular depression and neurocardiogenic syncope which has a temporal behavio
ur similar to the blood pressure variations of GBS. Conduction block of sin
oatrial stretch receptors causes inappropriate secretion of ADH and renin.
Disbalance between myelinated and unmyelinated afferents which decrease and
increase heart rate may cause parasympathetic hyperactivity, as exemplifie
d by pulmonary stretch receptors that are stimulated by artificial ventilat
ion. Wrong afferent feedback is responsible for many cardiovascular instabi
lities in GBS. Blockade of misguided efferent reactions is an attractive th
erapeutical approach.